Back

App-based multimodal lifestyle-intervention for essential hypertension: a randomized-controlled, decentralized trial in Germany

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Therapeutic approaches to hypertension and its comorbidities Lifestyle Modification ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Florian Limbourg

Hannover Medical School, Hannover (Germany)

3 More presentations in this session

Presentation thumbnail
The effect of a selective urate reabsorption inhibitor dotinurad on uric acid and renal function in patients with hyperuricemia and hypertension.
Doctor T. Mizoguchi (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Blood pressure lowering treatment for prevention of cardiovascular diseases in people with and without chronic kidney disease: an individual participant-level data meta-analysis
Ms G. Zeng (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of plateau on antihypertensive efficacy among hypertensive highlanders : a post hoc analysis of the OMAN Trial
Doctor X. Zuo (Sichuan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Therapeutic approaches to hypertension and its comorbidities

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
The past, present, and future of digital blood pressure-lowering interventions
thumbnail
Congress Presentation
Telemonitoring with biweekly telephone intervention enhances blood pressure control in uncontrolled hypertension: a randomized-controlled pilot study.
thumbnail
Congress Presentation
Hot papers on digital health in hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources